Tech Company Financing Transactions
Cohera Medical Funding Round
Private investors participated in a $8.4 million Series D capital raise for Cohera Medical. The financing round closed on 6/27/2012.
Transaction Overview
Company Name
Announced On
6/27/2012
Transaction Type
Venture Equity
Amount
$8,400,000
Round
Series D
Investors
Proceeds Purpose
The Company will use the funds to expand adoption in Germany and additional European markets for its lead product, TissuGlu Surgical Adhesive. The funds will also be used to support the clinical trials for TissuGlu in the United States, as well as the development and advancement of pipeline products, including FlexSil Surgical Sealant, an innovative surgical sealant for bowel repair with a billion dollar market potential.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
227 Fayetteville St. 900
Raleigh, NC 27601
USA
Raleigh, NC 27601
USA
Phone
Website
Email Address
Overview
Cohera Medical, Inc. is aimed at fulfilling the market demand for a strong, safe tissue adhesive to improve the wound closure process by positioning tissues for optimal healing while minimizing fluid accumulation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Patrick Daly
Chief Scientific Officer
Dottie Clower
Vice President
Mart Pearson
VP - Finance
Justin Alexander
VP - General Counsel
Chad Coberly
VP - Sales
John Wyatt
Browse more venture capital transactions:
Prev: 6/27/2012: Chill.com venture capital transaction
Next: 6/27/2012: GloStream venture capital transaction
Share this article
Where The Data Comes From
We do our best to document all VC transactions involving tech companies. All VC database entries reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs